Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $250.0000 (-3.85%) ($230.0000 - $260.0000) on Mon. Dec. 6, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.88% (three month average) | RSI | 40 | Latest Price | $250.0000(-3.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.2% a day on average for past five trading days. | Weekly Trend | CAPR declines -8.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.94% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.94% (StdDev 5.88%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
Resistance Level | $290.74 | 5 Day Moving Average | $251.6(-0.64%) | 10 Day Moving Average | $263.1(-4.98%) | 20 Day Moving Average | $290.74(-14.01%) | To recent high | -34.7% | To recent low | 2% | Market Cap | $4.924b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |